XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2022 25,027,467        
Beginning Balance at Dec. 31, 2022 $ 3 $ 333,558 $ (36,515) $ 87,708 $ 384,754
Other comprehensive income, net of tax 0 0 5,474 0 5,474
Stock-based compensation $ 0 3,450 0 0 3,450
Issuance of common stock via employee stock purchase plan (in shares) 7,724        
Issuance of common stock via employee stock purchase plan $ 0 394 0 0 394
Issuance of common stock via equity incentive plan (in shares) 41,685        
Issuance of common stock via equity incentive plan $ 0 90 0 0 90
Repurchases of common stock (in shares) (134,680)        
Repurchases of common stock $ 0 0 0 (6,826) (6,826)
Net income $ 0 0 0 17,313 17,313
Balance (in shares) at Mar. 31, 2023 24,942,196        
Balance at end of period at Mar. 31, 2023 $ 3 337,492 (31,041) 98,195 404,649
Balance (in shares) at Dec. 31, 2023 24,772,987        
Beginning Balance at Dec. 31, 2023 $ 3 350,597 (23,991) 144,643 471,252
Other comprehensive income, net of tax 0 0 (2,514) 0 (2,514)
Stock-based compensation $ 0 3,820 0 0 $ 3,820
Issuance of common stock via employee stock purchase plan (in shares) 9,806       9,806
Issuance of common stock via employee stock purchase plan $ 0 434 0 0 $ 434
Issuance of common stock via equity incentive plan (in shares) 138,267        
Issuance of common stock via equity incentive plan $ 0 1,857 0 0 1,857
Net income 0 0 0 26,382 26,382
Policyholder contribution to surplus $ 0 427 0 0 427
Balance (in shares) at Mar. 31, 2024 24,921,060        
Balance at end of period at Mar. 31, 2024 $ 3 $ 357,135 $ (26,505) $ 171,025 $ 501,658